These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 34299322)

  • 1. Neural Stem Cells for Early Ischemic Stroke.
    Hamblin MH; Lee JP
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural stem cell therapy for subacute and chronic ischemic stroke.
    Boese AC; Le QE; Pham D; Hamblin MH; Lee JP
    Stem Cell Res Ther; 2018 Jun; 9(1):154. PubMed ID: 29895321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains.
    Boese AC; Eckert A; Hamblin MH; Lee JP
    Exp Neurol; 2020 Jul; 329():113275. PubMed ID: 32147438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bystander Effect Fuels Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells to Quickly Attenuate Early Stage Neurological Deficits After Stroke.
    Eckert A; Huang L; Gonzalez R; Kim HS; Hamblin MH; Lee JP
    Stem Cells Transl Med; 2015 Jul; 4(7):841-51. PubMed ID: 26025980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous Neural Stem Cell-induced Neurogenesis after Ischemic Stroke: Processes for Brain Repair and Perspectives.
    Tang H; Li Y; Tang W; Zhu J; Parker GC; Zhang JH
    Transl Stroke Res; 2023 Jun; 14(3):297-303. PubMed ID: 36057034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of gene expression on a transcriptome-wide level following human neural stem cell transplantation in aged mouse stroke brains.
    Hamblin MH; Murad R; Yin J; Vallim G; Lee JP
    Exp Neurol; 2022 Jan; 347():113913. PubMed ID: 34752785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal neural crest stem cell transplantation as a promising therapeutic strategy for ischemic stroke.
    Salehi MS; Pandamooz S; Safari A; Jurek B; Tamadon A; Namavar MR; Dianatpour M; Dargahi L; Azarpira N; Fattahi S; Shid Moosavi SM; Keshavarz S; Khodabandeh Z; Zare S; Nazari S; Heidari M; Izadi S; Poursadeghfard M; Borhani-Haghighi A
    CNS Neurosci Ther; 2020 Jul; 26(7):670-681. PubMed ID: 32281225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.
    Adibhatla RM; Hatcher JF
    CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):243-53. PubMed ID: 18673209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroserpin and Extracellular Vesicles in Ischemic Stroke: Partners in Neuroprotection?
    Brenna S; Glatzel M; Magnus T; Puig B; Galliciotti G
    Aging Dis; 2024 Oct; 15(5):2191-2204. PubMed ID: 39191396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural stem cell transplantation in ischemic stroke: A role for preconditioning and cellular engineering.
    Bernstock JD; Peruzzotti-Jametti L; Ye D; Gessler FA; Maric D; Vicario N; Lee YJ; Pluchino S; Hallenbeck JM
    J Cereb Blood Flow Metab; 2017 Jul; 37(7):2314-2319. PubMed ID: 28303738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator.
    Jin R; Yang G; Li G
    Neurobiol Dis; 2010 Jun; 38(3):376-85. PubMed ID: 20302940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain.
    Petro M; Jaffer H; Yang J; Kabu S; Morris VB; Labhasetwar V
    Biomaterials; 2016 Mar; 81():169-180. PubMed ID: 26735970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural Stem Cells Therapy for Ischemic Stroke: Progress and Challenges.
    Zhao T; Zhu T; Xie L; Li Y; Xie R; Xu F; Tang H; Zhu J
    Transl Stroke Res; 2022 Oct; 13(5):665-675. PubMed ID: 35032307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke.
    Sifat AE; Vaidya B; Abbruscato TJ
    AAPS J; 2017 Jul; 19(4):957-972. PubMed ID: 28484963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural stem cells genetically modified to overexpress cu/zn-superoxide dismutase enhance amelioration of ischemic stroke in mice.
    Sakata H; Niizuma K; Wakai T; Narasimhan P; Maier CM; Chan PH
    Stroke; 2012 Sep; 43(9):2423-9. PubMed ID: 22713489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment.
    Knecht T; Story J; Liu J; Davis W; Borlongan CV; Dela Peña IC
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
    Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
    FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transduction of neural precursor cells with TAT-heat shock protein 70 chaperone: therapeutic potential against ischemic stroke after intrastriatal and systemic transplantation.
    Doeppner TR; Ewert TA; Tönges L; Herz J; Zechariah A; ElAli A; Ludwig AK; Giebel B; Nagel F; Dietz GP; Weise J; Hermann DM; Bähr M
    Stem Cells; 2012 Jun; 30(6):1297-310. PubMed ID: 22593021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.